三月—March

Sui is hovering around $1.02 right now. While most people are busy arguing over which Layer 1 is better, this chain is quietly putting up some crazy growth numbers. Year-over-year, active addresses are up 83%, transactions have jumped 77%, and network fees have spiked over 260%. Real people are actually using this network and moving capital onto it, which is the exact kind of organic activity you want to see before a big move. $SUI
The DeFi ecosystem on Sui is scaling fast too, with TVL sitting solid at $566M. Big protocols like Suilend and NAVI are leading the charge, locking in over $700M and $680M respectively. On top of that, the network is moving over $2.5B in stablecoins every single month. When you have that much actual cash flowing through a network, it’s only a matter of time before the token price starts catching up.
The biggest catalyst coming up is the Sui Stack (S2) upgrade. Mysten Labs is building this to turn Sui into a super clean developer platform, bringing in built-in privacy, a native stablecoin, and completely free stablecoin transfers. Taking gas fees out of stablecoin transactions is a massive deal that could easily bring a wave of regular, non-crypto users onto the chain.
Even Wall Street is starting to take notice. Franklin Templeton, a massive asset manager with $1.5T under management, is actively building on Sui. When a financial giant of that scale chooses Sui to deploy their digital asset projects, it is a huge stamp of legitimacy that most other mid-cap networks can only dream of.
My honest take? The tech and the big-money partnerships are top-tier, but you still have to watch the token unlocks. Sui has consistent monthly unlocks. Like the 74M token unlock that just hit on May 1 that constant stream of new supply means buyers have to keep stepping up to absorb it. Also, even with the recent growth, the TVL is still a long way off from its $2.2B peak back in late 2025.
Things are starting to look clean after a nice 10% bounce this week. SUI has built a strong floor around the $0.90–$0.95 range, and with CME recently launching SUI futures, big institutional traders finally have a regulated way to buy in. If the buyers can push SUI clean past the key $1.05 resistance level, we could easily see a fast run back toward the yearly highs.
At the end of the day, Sui has grown from an experimental "Solana-killer" into a highly mature, serious network, and that massive 572% jump in protocol revenue proves it. If you want a solid L1 play that has survived the hype phase and is actually showing real-world growth, SUI is definitely one to keep on your radar.
#SUIPricePrediction #SUIUSDT

$HYPE
Hype is sitting in that $43–$45 zone, and if you are still looking at traditional L1s for real yield, you are completely missing the plot.
Hyperliquid is officially the undisputed king of on-chain revenue, pulling in actual trading fees from real users rather than relying on empty inflation or VC hype. 97% of those fees go straight into buying back HYPE from the open market, creating a massive, automated bid that directly links platform growth to the token’s value.
The numbers they are pulling are actually ridiculous. We are talking $50.58M in fees just over the last 30 days, which puts them on track for an insane $607M annualized run rate. Even with Q1 2026 fees cooling down to $215M from the massive $287M peak we saw in Q4 2025, the sheer scale of this protocol is unmatched.
They have processed over $4T in all-time volume and are currently holding down a massive 70% to 80% of the entire on-chain perps market share.
On-chain data shows the biggest players are locking in for the long haul. Just a few days ago on May 6, a massive whale yanked $15.2M worth of HYPE off Coinbase and threw it straight into staking, which is a massive vote of confidence. Meanwhile, the degenerate energy on the platform is still wild.
Another whale opening a massive $20.3M BTC short at 40x leverage. The liquidity is deep enough to handle institutional-sized plays without breaking a sweat.
When you stack hyperliquid up against its competitors, the gap is almost embarrassing. Hyperliquid is currently generating 22 times more monthly fees than GMX and a staggering 189 times more than dYdX.
The protocol revenue generated per dollar of its market cap is easily among the highest in the entire crypto space, making most other DeFi governance tokens look like ghost towns.
My take? The tokenomics here are easily some of the best designed in the entire market, but do not ignore the massive supply unlocks.
We just saw a massive $375M token unlock hit in April, and even though the market absorbed it beautifully because of the aggressive buyback engine, massive unlocks always pose a dilution risk if trading volumes start to slide.
The expansion into real-world assets (RWA) via their HIP-3 upgrade is pulling huge volume, traditional commodities bring regulatory eyes that decentralized protocols usually try to avoid.
Technically, the chart is coiling up for something big. We are sitting right under a major resistance cluster between $43.76 and $45.77, and the market has been consolidating here after a massive run from its yearly lows.
If the bulls can find the momentum to clear this zone and print a daily close above $45.77, the path opens up for a fast, aggressive run toward $50 and beyond.
If you are looking for a project backed by actual cash flow, real-world utility, and a massive structural buyback engine, this is the one to keep on your radar. The gap between Hyperliquid’s massive fee generation and the rest of the stagnant DeFi market is exactly where the smart money is positioning.
#hypeusdt #dex #BlackRockPlansMoneyMarketFundsforStablecoinUsers

$BIO is low-key putting the entire DeSci sector on its back. This decentralized life-sciences play is funding real pharmaceutical research on-chain for a fraction of what conventional Big Pharma spends. The narrative is shifting fast because people are starting to realize that tokenizing actual scientific intellectual property is a massive game-changer.
The on-chain activity they just pulled off is wild. We saw $BIO pull in a massive $202.5M in 24-hour trading volume, which was a crazy 185% spike from the previous day. This surge triggered right after a major research milestone demonstrated actual, real-world drug discovery output. People aren't just trading vibes here. they are trading actual scientific breakthroughs.
This protocol is the undisputed heavyweight champion of the decentralized science space right now. It currently commands about 20% of the entire $315M DeSci sector market cap, making it the main liquidity anchor for the whole movement. When a single project holds that much dominance, it dictates exactly where the rest of the sector goes.
The smart money is already drawing massive parallels to the early DeFi Summer of 2020. Back then, projects with actual, working use cases suddenly emerged and sparked sector-wide rallies that went up thousands of percent. If DeSci is indeed the next mega-narrative, $BIO is sitting right at the front of the bus.
My take? Do not get completely blinded by the hype, because clinical trials take years and biotech has a brutal failure rate. An AI agent like peptAI designing an ADHD drug candidate in 24 hours is a massive flex, but actually getting a compound through FDA trials is a completely different beast that won't happen overnight. Plus, with a multisig recently moving 80 million tokens to exchanges and the asset sitting in extreme greed territory, a heavy pullback is highly likely.
But you gotta keep your head on straight because this is still an incredibly small-cap asset. With a tiny market cap, the upside potential is absolutely astronomical, but the downside volatility will test your stomach. You can expect massive price swings, heavy retracements, and crazy liquidations if you chase the green candles too late.